Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study.

This nationwide study, which is the largest to date, suggests that treatment with clozapine is associated with a reduction in psychiatric admissions and inpatient days in patients with intellectual disability. Further studies evaluating the effects of clozapine in patients with intellectual disability are warranted.